PKM2-Loaded Vesicles Clear Senescent Cells to Treat Chronic Periodontitis

Chronic periodontitis affects millions worldwide and creates persistent inflammation that extends beyond the mouth to cause systemic health problems. This study reveals a previously unknown connection between gum disease and cellular aging processes throughout the body.

Researchers used mouse models of chronic periodontitis and analyzed blood samples from patients to understand how gum inflammation affects cellular function. They discovered that chronic periodontitis causes cells to become resistant to normal death processes (apoptotic resistance) and accumulate as senescent cells that perpetuate inflammation.

The key breakthrough was identifying reduced levels of PKM2 protein in circulating vesicles from periodontitis patients and mice. PKM2 normally helps regulate cell death and inflammation when present in cell nuclei. The team developed a therapy using apoptotic vesicles from mesenchymal stem cells loaded with PKM2 protein.

When administered systemically to mice with chronic periodontitis, these PKM2-loaded vesicles successfully eliminated senescent cells and significantly reduced gum inflammation and bone loss. The treatment worked by delivering PKM2 directly to cell nuclei and promoting phosphorylation that enhances PKM2's nuclear import, restoring normal cellular death processes.

This research suggests that targeting senescent cells could be a new therapeutic approach for periodontitis, moving beyond current treatments that focus only on local infection control. The systemic nature of the therapy addresses both local gum inflammation and broader metabolic dysfunction associated with chronic periodontitis.